Showing results (151-160 of 929) with videos related to
Sort By:
Pageof 93
Current Pharmaceutical Design|February 1, 2014
MicroRNAs as anti-cancer therapyMichela Garofalo, Gianpiero Di Leva, Carlo M CroceInternational Reviews of Immunology|October 9, 2009
miR-155: on the crosstalk between inflammation and cancerEsmerina Tili, Carlo M Croce, Jean-Jacques MichailleUpsala Journal of Medical Sciences|February 22, 2012
MicroRNA in cancer: new hopes for antineoplastic chemotherapyGianpiero Di Leva, Daniel Briskin, Carlo M CroceAdvances in Hematology|April 5, 2011
Micro-RNA Expression and Function in LymphomasSukhinder K Sandhu, Carlo M Croce, Ramiro GarzonPharmacological Reviews|November 25, 2025
miR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor responseEsmerina Tili, Jean-Jacques Michaille, Carlo M CroceProceedings of the National Academy of Sciences of the United States of America|March 22, 2006
MicroRNA fingerprints during human megakaryocytopoiesisRamiro Garzon, Flavia Pichiorri, Tiziana Palumbo, et al.Blood|June 11, 2014
MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemiaBing Cui, Liguang Chen, Suping Zhang, et al.Trends in Genetics : TIG|November 3, 2021
Classical and noncanonical functions of miRNAs in cancersMihnea P Dragomir, Erik Knutsen, George A CalinGenes, Chromosomes & Cancer|April 3, 2015
Tracking miRNAs' footprints in tumor-microenvironment interactions: Insights and implications for targeted cancer therapyNazila Nouraee, Seyed Javad Mowla, George A CalinCurrent Medicinal Chemistry|July 10, 2013
MicroRNAs and cancer therapy - from bystanders to major playersCornelia Braicu, George A Calin, Ioana Berindan-NeagoePageof 93